Drugs Information: Vedolizumab
Basic Information
|
||
| ID | DDInter1923 | |
| Drug Type | biotech | |
| Molecular Formula | C6528H10072N1732O2042S42 | |
| Molecular Weight | - | |
| Description | Vedolizumab is an integrin blocker and anti-inflammatory agent used to manage ulcerative colitis and Crohn's disease in adults with inadequate clinical response to immunomodulators. | |
| ATC Classification | L04AA33 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Vedolizumab
| Severity level | ID | Name | Mechanism | Detail |
|---|